Please complete the CAPTCHA to continue
@artaxbiopharma.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Luc Marti is listed as Director of Clinical Development Medibiofarma at MEDIBIOFARMA SL, based in Greater Barcelona Metropolitan Area, Spain. AeroLeads shows a work email signal at artaxbiopharma.com and a matched LinkedIn profile for Luc Marti.
Luc Marti previously worked as Director of Clinical Development at Medibiofarma Sl and Chief Operating Officer at Cebiotex. Luc Marti holds Master, Biotechnology Management (Online Mbm2010 from Ie Business School.
This section adds company-level context without repeating Luc Marti's masked contact details.
AeroLeads found 1 current-domain work email signal for Luc Marti. Compare company email patterns before reaching out.
Drug Developper Director of Operations/R&D PhD in PharmacologyManagement of all steps up to clinical phase 2a, including Tox, GMP, and Clinic.Obtained 8 authorizations for clinical trials (UK, Spain).Therapies: Small molecules, implantable drug delivery systemsTherapeutic areas: Metabolic syndrome, Cancer, Autoimmune diseases, IBD, NeuroCRO selection & Contracts negociations.Meetings with National EU agencies, EMA and FDABoth directions due diligenciesCommunication with investors & Board members
Listed skills include Biotechnology, R&D, Drug Discovery, Clinical Trials, and 16 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Noáin, Navarra, Es
Therapeutic Areas: Neuro, IBD, Cancer In charge of three clinical programs. Coordination of all clinical activities including regulatory and operations Writing and review of all the documentation Relationships with CROs (clinic / PK / PD), IP, nurses, study coordinatorsCoordination of GMP manufacture to avoid any product disruption at the Hospital pharmaciesVery High Quality standards
Barcelona, Catalonia, Es
R&D• Implementation of pharma standards in the company• Improvement of product formulation prior to regulatory development• Design and Coordination of in vitro and in vivo data in the chosen cancer indication• Design and Coordination of non-regulatory and regulatory toxicology studies• Coordination of production plant activities required for GMP certification• Obtention of a GMP certificate for the manufacture of matrix implant drug product• Coordination of Regulatory paper work (IMPD, IB, Protocol)• Coordination of the clinical trialMiscellaneous• Obtention of an Orphan Drug Designation (ODD) at EMA for the use of CEB-01 in Soft tissue sarcoma• Meetings at European and Spanish medicine agencies• 1 patent filled
Selection of CROs and academic labs, contracts negociations, and management of all external collaborations for R&D program, including discovery, regulatory toxicology, CMC, clinic. Whole activities representing close to 80 people located in EU, US, Asia. Selection and coordination of consultants activities.Discovery: Driving discovery efforts in the field of autoimmune disease, peptides synthesis, X-ray protein structure, virtual screening/docking, H2L screening cascade design, lead optimization.Toxicology: deeply involved in protocol and data discussions for full package studies up to 13 weeks studies and reprotox.CMC: coordination of programs from non-GMP to GMP batchs, including drug product formulation.Clinic: Coordination of regulatory submissions (IB, IMPD) for phase 1a and phase 1b/2a. Writing of clinical synopsis/protocol for clinical phase 1a, 1b and 2a. Key input in dose escalating schedule, PK interpretation and doses selection.Participation to data package for investors and participation to discussions.
Implementation of the companyR&D in metabolic diseases and inflammationDrug development including discovery, tox preclinic, and clinicCoordination of paper work for a Phase zero, phase 1a, Phase 1b, and support to Phase 2aFDA and european agencies meetingsParticipation to the company setup - Recruitment of -1 and 1 levelsRegular reporting to the Scientific Advisory BoardMore than 10 patent filingsCROs' Contracts negotiations, and management
Pharmacology / Diabetes / Inflammation1 patent30 international scientific publicationsDirector of 2 Ph.D. thesesDiscovery and characterisation of a new anti-diabetic compoundManagement of Research projects
Biosensors for insecticide detection using quartz based detection coupled to enzyme immobilisation technicsA great opportunity to discover Asian culture.
Quick answers generated from the profile data available on this page.
Luc Marti works for MEDIBIOFARMA SL.
Luc Marti is listed as Director of Clinical Development Medibiofarma at MEDIBIOFARMA SL.
AeroLeads has found 1 work email signal at @artaxbiopharma.com for Luc Marti at MEDIBIOFARMA SL.
Luc Marti is based in Greater Barcelona Metropolitan Area, Spain while working with MEDIBIOFARMA SL.
Luc Marti has worked for Medibiofarma Sl, Cebiotex, Artax Biopharma, Genmedica Therapeutics, and Barcelona Science Park.
You can use AeroLeads to view verified contact signals for Luc Marti at MEDIBIOFARMA SL, including work email, phone, and LinkedIn data when available.
Luc Marti holds Master, Biotechnology Management (Online Mbm2010 from Ie Business School.
Luc Marti is listed with skills including Biotechnology, R&D, Drug Discovery, Clinical Trials, Type 2 Diabetes, Biochemistry, Toxicology, and Cell Biology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts